Supplementary Table from Onartuzumab (MetMAb): Using Nonclinical Pharmacokinetic and Concentration–Effect Data to Support Clinical Development

Authors :: Lisa A. Damico-Beyer
Amy Peterson
Judy Young
Elaine Mai
Ihsan Nijem
Teresa Davancaze
Mally Romero
Nelson L. ‘Shasha’ Jumbe
Mark Merchant
Arthur E. Reyes
Brendan C. Bender
Hong Xiang
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file, 54K, Estimation of percentage of patients to achieve TSC (15 ug/mL) at Ctrough ss with Q3W dose regimen.

Full Text Access

Tools